These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 21150770)

  • 1. Recent advances in prodrugs as drug delivery systems.
    Lin C; Sunkara G; Cannon JB; Ranade V
    Am J Ther; 2012 Jan; 19(1):33-43. PubMed ID: 21150770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of dendrimers and drug-dendrimer conjugates for drug delivery.
    Najlah M; D'Emanuele A
    Curr Opin Drug Discov Devel; 2007 Nov; 10(6):756-67. PubMed ID: 17987527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prodrugs: design and clinical applications.
    Rautio J; Kumpulainen H; Heimbach T; Oliyai R; Oh D; Järvinen T; Savolainen J
    Nat Rev Drug Discov; 2008 Mar; 7(3):255-70. PubMed ID: 18219308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prodrugs--from serendipity to rational design.
    Huttunen KM; Raunio H; Rautio J
    Pharmacol Rev; 2011 Sep; 63(3):750-71. PubMed ID: 21737530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances in retrometabolic drug design and targeting approaches.
    Bodor N
    Pharmazie; 2000 Mar; 55(3):163-6. PubMed ID: 10756533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymeric prodrugs.
    Azori M
    Crit Rev Ther Drug Carrier Syst; 1987; 4(1):39-65. PubMed ID: 3315236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Research of oral prodrugs: opportunities and challenges].
    Cao F; Ping QN; Chen J
    Yao Xue Xue Bao; 2008 Apr; 43(4):343-9. PubMed ID: 18664193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amino acids as promoieties in prodrug design and development.
    Vig BS; Huttunen KM; Laine K; Rautio J
    Adv Drug Deliv Rev; 2013 Oct; 65(10):1370-85. PubMed ID: 23099277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prodrug approaches for CNS delivery.
    Rautio J; Laine K; Gynther M; Savolainen J
    AAPS J; 2008; 10(1):92-102. PubMed ID: 18446509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Remarkable drug-release enhancement with an elimination-based AB3 self-immolative dendritic amplifier.
    Sagi A; Segal E; Satchi-Fainaro R; Shabat D
    Bioorg Med Chem; 2007 Jun; 15(11):3720-7. PubMed ID: 17416532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strategies to improve oral drug bioavailability.
    Gomez-Orellana I
    Expert Opin Drug Deliv; 2005 May; 2(3):419-33. PubMed ID: 16296764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What should be considered on design of a colon-specific prodrug?
    Jung Y; Kim YM
    Expert Opin Drug Deliv; 2010 Feb; 7(2):245-58. PubMed ID: 20095945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemistry-enabled drug delivery (prodrugs): recent progress and challenges.
    Clas SD; Sanchez RI; Nofsinger R
    Drug Discov Today; 2014 Jan; 19(1):79-87. PubMed ID: 23993918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmaceutical approaches to colon targeted drug delivery systems.
    Chourasia MK; Jain SK
    J Pharm Pharm Sci; 2003; 6(1):33-66. PubMed ID: 12753729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Approaches towards enhanced transepithelial drug delivery.
    Majumdar S; Mitra AK
    Discov Med; 2006 Dec; 6(36):229-33. PubMed ID: 17250788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prodrug strategies to overcome poor water solubility.
    Stella VJ; Nti-Addae KW
    Adv Drug Deliv Rev; 2007 Jul; 59(7):677-94. PubMed ID: 17628203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diverse approaches for the enhancement of oral drug bioavailability.
    Fasinu P; Pillay V; Ndesendo VM; du Toit LC; Choonara YE
    Biopharm Drug Dispos; 2011 May; 32(4):185-209. PubMed ID: 21480294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prodrugs: Some thoughts and current issues.
    Stella VJ
    J Pharm Sci; 2010 Dec; 99(12):4755-65. PubMed ID: 20821387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prodrug approaches to reduce hyperexcitation in the CNS.
    Vytla D; Combs-Bachmann RE; Hussey AM; McCarron ST; McCarthy DS; Chambers JJ
    Adv Drug Deliv Rev; 2012 May; 64(7):666-85. PubMed ID: 22138074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prodrugs as drug delivery systems. 74. Facile hydrolysis of N-(acyloxymethyl)amide derivatives and implications for the design of prodrugs of NH-acidic compounds and of carboxylic acids.
    Bundgaard H; Nielsen NM
    Acta Pharm Suec; 1987; 24(5):233-46. PubMed ID: 3450189
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.